Brookfield Real Assets Income Fund Inc.(RA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RA Brookfield Real Assets Income Fund Inc.

交易中 09-10 10:22:32 EDT

12.26

-0.05

-0.38%

最高12.29	最低12.24	成交量6.51万
今开12.25	昨收12.30	日振幅0.41%
总市值6.77亿	流通市值6.77亿	总股本5,525万
成交额79.83万	换手率0.12%	流通股本5,525万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RA","market":"US","secType":"STK","nameCN":"Brookfield Real Assets Income Fund Inc.","latestPrice":12.255,"timestamp":1789050061588,"preClose":12.302,"halted":0,"volume":65118,"delay":0,"changeRate":-0.0038205169891073663,"floatShares":55245934,"shares":55254696,"eps":1.18,"marketStatus":"交易中","change":-0.047,"latestTime":"09-10 10:22:32 EDT","open":12.2451,"high":12.2899,"low":12.24,"amount":798286.836558,"amplitude":0.004056,"askPrice":12.35,"askSize":100,"bidPrice":12.25,"bidSize":100,"shortable":3,"etf":0,"ttmEps":1.18,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":12.302,"dividendRate":0.115496,"preHourTrading":{"tag":"盘前","latestPrice":12.32,"preClose":12.302,"latestTime":"09:23 EDT","volume":213,"amount":2626.666158,"timestamp":1789046584959,"change":0.018,"changeRate":0.001463,"amplitude":0.019086},"postHourTrading":{"tag":"盘后","latestPrice":12.42,"preClose":12.42,"latestTime":"19:30 EDT","volume":1937,"amount":24060.4,"timestamp":1788996609275,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":3.290918},"requestUrl":"/m/hq/s/RA","defaultTab":"news","newsList":[{"id":"1186611042","title":"Equillium获RA资本管理3500万美元融资 加速EQ504临床开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1186611042","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186611042?lang=zh_cn&edition=full","pubTime":"2026-03-13 20:05","pubTimestamp":1773403550,"startTime":"0","endTime":"0","summary":"此次融资将强化公司资产负债表，推动关键候选药物EQ504跨越临床里程碑。预计净收益与现有现金储备将支撑公司运营至2029年。2026年3月13日，专注于治疗严重自身免疫及炎症疾病的生物技术公司Equillium Inc.宣布与RA资本管理达成最终证券购买协议，后者将提供约3500万美元的总融资。在扣除相关费用前，本次融资总额预计达3500万美元。Equillium认为EQ504单药或联合疗法在溃疡性结肠炎领域具有广阔治疗潜力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RA","BK4139","BK4568","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517088192","title":"Igm Biosciences, Inc.盘中异动 下午盘股价大涨5.19%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517088192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517088192?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:48","pubTimestamp":1741290530,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时48分，Igm Biosciences, Inc.股票出现波动，股价急速上涨5.19%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司，用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307034851989eeaf8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307034851989eeaf8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","RA","SLE","BK4139","IGMS","BK4077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517198212","title":"Anaptysbio, Inc.盘中异动 大幅跳水5.07%报15.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517198212","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517198212?lang=zh_cn&edition=full","pubTime":"2025-03-07 01:12","pubTimestamp":1741281178,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日01时12分，Anaptysbio, Inc.股票出现波动，股价大幅下跌5.07%。截至发稿，该股报15.90美元/股，成交量14.7412万股，换手率0.48%，振幅4.72%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为3191.22%、2706.07%、219.82%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为125.28%、105.20%、71.44%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307011259a262b72b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307011259a262b72b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","ANAB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517288319","title":"Anaptysbio, Inc.盘中异动 大幅上涨5.05%报16.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517288319","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517288319?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:54","pubTimestamp":1741197250,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时54分，Anaptysbio, Inc.股票出现异动，股价大幅拉升5.05%。截至发稿，该股报16.02美元/股，成交量18.796万股，换手率0.61%，振幅5.49%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为1.33%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Celularity Inc.涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为943.09%、304.49%、296.64%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.，振幅分别为82.59%、54.27%、47.22%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306015411a260fff8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306015411a260fff8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","BK4139","ANAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517600468","title":"Anaptysbio, Inc.盘中异动 下午盘股价大涨5.09%报15.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517600468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517600468?lang=zh_cn&edition=full","pubTime":"2025-03-05 02:57","pubTimestamp":1741114670,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日02时57分，Anaptysbio, Inc.股票出现异动，股价大幅上涨5.09%。截至发稿，该股报15.39美元/股，成交量41.7006万股，换手率1.36%，振幅9.36%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305025751963983e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305025751963983e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANAB","RA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516300176","title":"Anaptysbio, Inc.盘中异动 早盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516300176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516300176?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:40","pubTimestamp":1741016416,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时40分，Anaptysbio, Inc.股票出现异动，股价大幅下跌5.05%。截至发稿，该股报15.97美元/股，成交量12.1312万股，换手率0.40%，振幅7.55%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2270.71%、137.53%、130.63%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为177.97%、70.53%、50.09%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303234016abe64b2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303234016abe64b2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANAB","RA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516801658","title":"Igm Biosciences, Inc.盘中异动 股价大跌5.15%报1.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516801658","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516801658?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:38","pubTimestamp":1741016320,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时38分，Igm Biosciences, Inc.股票出现波动，股价大幅下跌5.15%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aldeyra Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2194.18%、136.84%、130.26%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为177.97%、70.53%、49.80%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司，用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303233840989a2119&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303233840989a2119&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4077","RA","BK4505","SLE","BK4139","IGMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514320113","title":"Anaptysbio, Inc.股价拉升13.90% 市值涨7900.87万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514320113?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:32","pubTimestamp":1740753149,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时32分，Anaptysbio, Inc.股票出现异动，股价大幅拉升13.90%。截至发稿，该股报18.68美元/股，成交量1.6566万股，换手率0.05%，振幅6.76%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为483.12%、240.91%、59.40%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Trevi Therapeutics, Inc.、Spyre Therapeutics, Inc.，振幅分别为31.14%、8.44%、8.03%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223229abe0eab0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223229abe0eab0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","RA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514331713","title":"Anaptysbio, Inc.盘中异动 下午盘股价大跌5.03%报16.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514331713?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:33","pubTimestamp":1740684818,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时33分，Anaptysbio, Inc.股票出现异动，股价快速下跌5.03%。截至发稿，该股报16.15美元/股，成交量25.5381万股，换手率0.84%，振幅6.44%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Alpha Tau Medical Ltd C/Wts 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1903.69%、330.34%、183.70%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280333389632e8b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280333389632e8b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","ANAB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514091851","title":"Igm Biosciences, Inc.盘中异动 股价大涨5.34%报1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514091851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514091851?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:31","pubTimestamp":1740580280,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时31分，Igm Biosciences, Inc.股票出现波动，股价大幅上涨5.34%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Enveric Biosciences, Inc.、Cns Pharmaceuticals, Inc.、Immunoprecise Antibodies Ltd.涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2656.89%、113.38%、85.43%，振幅较大的相关个股有Enveric Biosciences, Inc.、Allarity Therapeutics, Inc.、Cns Pharmaceuticals, Inc.，振幅分别为16.95%、8.96%、8.43%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司，用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223120a254f633&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223120a254f633&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLE","IGMS","BK4077","BK4505","RA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513720545","title":"Igm Biosciences, Inc.盘中异动 快速跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513720545?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:05","pubTimestamp":1740409521,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时05分，Igm Biosciences, Inc.股票出现异动，股价急速下跌5.07%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Pepgen Inc.、Telix Pharmaceutic、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为162.31%、71.07%、25.66%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、42.86%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司，用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230521abdb163f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230521abdb163f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4077","SLE","BK4505","RA","BK4139","IGMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513783137","title":"Anaptysbio, Inc.盘中异动 大幅下跌5.00%报17.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513783137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513783137?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:04","pubTimestamp":1740409470,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时04分，Anaptysbio, Inc.股票出现异动，股价急速下跌5.00%。截至发稿，该股报17.66美元/股，成交量6.791万股，换手率0.22%，振幅4.46%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Pepgen Inc.、Telix Pharmaceutic、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为159.65%、70.56%、25.66%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、42.86%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230430abdb15ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230430abdb15ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RA","ANAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513629910","title":"Igm Biosciences, Inc.盘中异动 急速拉升5.04%报1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513629910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513629910?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:47","pubTimestamp":1740149276,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时47分，Igm Biosciences, Inc.股票出现波动，股价大幅上涨5.04%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司，用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224756abd7b39a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224756abd7b39a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IGMS","RA","BK4077","SLE","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512648389","title":"Igm Biosciences, Inc.盘中异动 早盘股价大涨5.14%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512648389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512648389?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:46","pubTimestamp":1739976414,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时46分，Igm Biosciences, Inc.股票出现异动，股价急速上涨5.14%。截至发稿，该股报1.54美元/股，成交量1.5424万股，换手率0.03%，振幅5.47%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司，用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224654abd501eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224654abd501eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IGMS","BK4505","RA","BK4077","SLE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512169455","title":"Anaptysbio, Inc.盘中异动 早盘股价大跌5.00%报20.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512169455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512169455?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:16","pubTimestamp":1739891785,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时16分，Anaptysbio, Inc.股票出现异动，股价快速跳水5.00%。截至发稿，该股报20.16美元/股，成交量14.9729万股，换手率0.49%，振幅6.80%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Solid Biosciences Inc.、Allogene Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为352.34%、134.56%、127.46%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Allogene Therapeutics, Inc.，振幅分别为148.75%、51.40%、46.32%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218231625988a0646&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218231625988a0646&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","ANAB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512165957","title":"Igm Biosciences, Inc.盘中异动 股价大涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512165957?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:41","pubTimestamp":1739889666,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时41分，Igm Biosciences, Inc.股票出现异动，股价快速拉升5.59%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为300.86%、104.63%、84.83%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.、Pulmatrix, Inc.，振幅分别为34.04%、26.83%、23.16%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司，用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182241069627998e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182241069627998e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","RA","SLE","BK4077","IGMS","BK4007","PULM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511691734","title":"Anaptysbio, Inc.盘中异动 早盘急速上涨5.46%报20.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511691734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511691734?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:48","pubTimestamp":1739544537,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时48分，Anaptysbio, Inc.股票出现异动，股价大幅拉升5.46%。截至发稿，该股报20.34美元/股，成交量5.2291万股，换手率0.17%，振幅5.51%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1852.91%、485.12%、421.78%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.，振幅分别为66.93%、32.93%、32.49%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422485796231f69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422485796231f69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511569623","title":"Igm Biosciences, Inc.盘中异动 早盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511569623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511569623?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:45","pubTimestamp":1739544316,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时45分，Igm Biosciences, Inc.股票出现波动，股价快速拉升5.11%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1686.20%、454.74%、411.02%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.，振幅分别为66.93%、32.93%、32.49%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司，用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224517a246043c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224517a246043c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4077","IGMS","RA","BK4139","SLE","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511525181","title":"Anaptysbio, Inc.盘中异动 早盘股价大涨7.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525181","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511525181?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457063,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分，Anaptysbio, Inc.股票出现波动，股价快速拉升7.99%。截至发稿，该股报17.44美元/股，成交量7.5358万股，换手率0.25%，振幅0.80%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Tc Biopharm  Plc、Edesa Biotech, Inc.、Genprex, Inc.较为活跃，换手率分别为970.14%、764.83%、89.76%，振幅较大的相关个股有Enliven Therapeutics, Inc.、Aim Immunotech Inc.、Aditxt, Inc.，振幅分别为6.98%、5.37%、3.84%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322310498842b5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322310498842b5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510782335","title":"Anaptysbio, Inc.盘中异动 早盘股价大跌5.15%报12.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510782335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510782335?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:16","pubTimestamp":1739286983,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时16分，Anaptysbio, Inc.股票出现异动，股价快速下挫5.15%。截至发稿，该股报12.33美元/股，成交量4.3521万股，换手率0.14%，振幅4.77%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为1.58%。其相关个股中，Ocean Biomedical, Inc.、Dominari Holdings Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2551.71%、838.28%、342.49%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为52.11%、43.92%、37.99%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211231624961f508b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211231624961f508b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RA","ANAB","OCEA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://publicsecurities.brookfield.com","stockEarnings":[{"period":"1week","weight":-0.0088},{"period":"1month","weight":-0.0312},{"period":"3month","weight":-0.0135},{"period":"6month","weight":-0.0251},{"period":"1year","weight":-0.0847},{"period":"ytd","weight":-0.0417}],"compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0138},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1512},{"period":"1year","weight":0.1723},{"period":"ytd","weight":0.118}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Brookfield Real Assets Income Fund Inc.于2015年10月6日在马里兰州注册成立。这是一家多元化的封闭式管理投资公司。该基金的投资目标是寻求高总回报，主要是通过高当前收入，其次是通过资本增长。","yearOnYearQuotes":[{"month":1,"riseRate":0.9,"avgChangeRate":0.030782},{"month":2,"riseRate":0.5,"avgChangeRate":-0.000004},{"month":3,"riseRate":0.3,"avgChangeRate":-0.039784},{"month":4,"riseRate":0.7,"avgChangeRate":0.027537},{"month":5,"riseRate":0.3,"avgChangeRate":-0.011694},{"month":6,"riseRate":0.6,"avgChangeRate":0.001407},{"month":7,"riseRate":0.8,"avgChangeRate":0.021368},{"month":8,"riseRate":0.4,"avgChangeRate":-0.024385},{"month":9,"riseRate":0.2,"avgChangeRate":-0.023705},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.013215},{"month":11,"riseRate":0.444444,"avgChangeRate":0.010254},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.022912}],"exchange":"NYSE","name":"Brookfield Real Assets Income Fund Inc.","nameEN":"Brookfield Real Assets Income Fund Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Brookfield Real Assets Income Fund Inc.(RA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Brookfield Real Assets Income Fund Inc.(RA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Brookfield Real Assets Income Fund Inc.,RA,Brookfield Real Assets Income Fund Inc.股票,Brookfield Real Assets Income Fund Inc.股票老虎,Brookfield Real Assets Income Fund Inc.股票老虎国际,Brookfield Real Assets Income Fund Inc.行情,Brookfield Real Assets Income Fund Inc.股票行情,Brookfield Real Assets Income Fund Inc.股价,Brookfield Real Assets Income Fund Inc.股市,Brookfield Real Assets Income Fund Inc.股票价格,Brookfield Real Assets Income Fund Inc.股票交易,Brookfield Real Assets Income Fund Inc.股票购买,Brookfield Real Assets Income Fund Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Brookfield Real Assets Income Fund Inc.(RA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Brookfield Real Assets Income Fund Inc.(RA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}